Drug Landscape ›
VITAMIN K ›
Regulatory · United States
Marketing authorisation
FDA
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
Window: 20 April 2025 – 20 April 2026
Total reports: 3,183
Most-reported reactions
Fatigue — 388 reports (12.19%) Drug Ineffective — 379 reports (11.91%) Diarrhoea — 362 reports (11.37%) Off Label Use — 357 reports (11.22%) Nausea — 354 reports (11.12%) Dyspnoea — 299 reports (9.39%) Headache — 278 reports (8.73%) Pain — 269 reports (8.45%) Vomiting — 258 reports (8.11%) Pyrexia — 239 reports (7.51%)
Source database →
VITAMIN K in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is VITAMIN K approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for VITAMIN K in United States?
Marketing authorisation holder not available in our data.